Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy

被引：0
|
作者：
Maria D Cao
Guro F Giskeødegård
Tone F Bathen
Beathe Sitter
Anna Bofin
Per E Lønning
Steinar Lundgren
Ingrid S Gribbestad
机构：
[1] Norwegian University of Science and Technology (NTNU),Department of Circulation and Medical Imaging
[2] St Olavs University Hospital,Department of Laboratory Medicine
[3] Children's and Women's Health,Department of Oncology
[4] NTNU,Section of Oncology
[5] Haukeland University Hospital,Department of Oncology
[6] Institute of medicine,Department of Cancer Research and Molecular Medicine
[7] University of Bergen,Department of Circulation and Medical Imaging, The Faculty of Medicine
[8] St. Olavs Hospital,undefined
[9] University Hospital of Trondheim,undefined
[10] NTNU,undefined
[11] NTNU,undefined
[12] MTFS,undefined
来源：
BMC Cancer | / 12卷
关键词：
Breast Cancer Survival; Metabolic Response; Partial Little Square Discriminant Analysis; Partial Little Square Discriminant Analysis Model; Glycine Level;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
    Tari A. King
    Monica Morrow
    [J]. Nature Reviews Clinical Oncology, 2015, 12 : 335 - 343
  • [22] Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy
    Aaldriks, A. A.
    Giltay, E. J.
    le Cessie, S.
    van der Geest, L. G. M.
    Portielje, J. E. A.
    Tanis, B. C.
    Nortier, J. W. R.
    Maartense, E.
    [J]. BREAST, 2013, 22 (05): : 753 - 760
  • [23] Systemic staging in breast cancer patients receiving neoadjuvant chemotherapy
    Lattimore, Courtney
    Gabriella, Squeo
    Brenin, Christiana
    Showalter, Shayna
    Millard, Trish
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [24] Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
    King, Tari A.
    Morrow, Monica
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (06) : 335 - 343
  • [25] Tumor localization for breast cancer patients receiving neoadjuvant chemotherapy
    Wu, Zhen-Yu
    Kim, Namkug
    Ko, BeomSeok
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (02) : 531 - 532
  • [26] Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
    Chen, Li
    Kong, Xiangyi
    Huang, Shaolong
    Su, Zhaohui
    Zhu, Mengliu
    Fang, Yi
    Zhang, Lin
    Li, Xingrui
    Wang, Jing
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Metabolic Syndrome Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
    Lu, Ying
    Wang, Pinxiu
    Lan, Ning
    Kong, Fei
    Abdumijit, Awaguli
    Tu, Shiyan
    Li, Yanting
    Yuan, Wenzhen
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Prognostic Value of Genomic Analysis after Neoadjuvant Chemotherapy for Breast Cancer
    Mayer, E. L.
    Shak, S.
    Miller, K.
    Rugo, H.
    Carey, L.
    Ryabin, N.
    Pomeroy, C.
    Yoshizawa, C.
    Winer, E. P.
    Burstein, H. J.
    [J]. CANCER RESEARCH, 2010, 70
  • [29] Mammographic breast density: Predictive value for pathological response to neoadjuvant chemotherapy in breast cancer patients
    Elsamany, S.
    Alzahrani, A.
    Abozeed, W. N.
    Rasmy, A.
    Farooq, M. U.
    Elbiomy, M. A.
    Rawah, E.
    Alsaleh, K.
    Abdel-Aziz, N. M.
    [J]. BREAST, 2015, 24 (05): : 576 - 581
  • [30] The prognostic value of chemotherapy response score and lymphocytic infiltration ovarian cancer patients treated with neoadjuvant chemotherapy
    Liontos, M.
    Sotiropoulou, M.
    Kaparelou, M.
    Tzannis, K.
    Tsironis, G.
    Kyriazoglou, A.
    Tsiara, A.
    Zakopoulou, R.
    Rodolakis, I.
    Koutsoukos, K.
    Zagouri, F.
    Thomakos, N.
    Haidopoulos, D.
    Rodolakis, A.
    Bamias, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 83 - 84
12345